Psychedelics Small Pharma gets approval for upcoming injectable DMT trial on humans New phase I study will be held at MAC Clinical Research in Manchester, England next year Rowan DunneOctober 31, 2022
News Hexo to buy 48North Cannabis for $50M Amid a wave of consolidation, the Ottawa firm says the deal will give it a top-2 position in the Canadian adult-use weed market Jared GnamMay 17, 2021
News Harvest Health deal to test Trulieve’s industry-leading profits After posting a net income of US$30.1M in Q1, the Florida weed firm's merger with Harvest will test its industry-leading efficiency Jared GnamMay 13, 2021
News Tilray 1.0 quietly discloses first-quarter US$341M loss In the final quarter before merging with Aphria, Tilray shows fiscal weakness Jared GnamMay 11, 2021
News Curaleaf plans to stay on top of US pot boom After posting an industry-leading US$260M in Q1, the American weed giant eyes domination in NY, NJ and internationally Jared GnamMay 11, 2021
News Alabama joins recent red state drive for legal medical cannabis As Alabama's Legislature passes a medical cannabis bill, Louisiana, Kansas and Tennessee also made moves to open up legal patient access this week Jared GnamMay 7, 2021
News Cronos continues cash burn with US$161M loss in Q1 With revenue of just US$12.6M in Q1, the Canadian pot firm says it's finally ready to commercialize its synthetic cannabinoids joint venture Jared GnamMay 7, 2021
News Sundial to buy weed retailer Inner Spirit for $131M Calgary-based producer will get 86 Spiritleaf pot shops that Inner Spirit owns and franchises Jared GnamMay 5, 2021
News Organigram drops CEO shortly after big tobacco investment Since receiving $221M from British American Tobacco, the Canadian cannabis firm has reported declining revenue Jared GnamMay 3, 2021
News Texas House passes cannabis decriminalization bill In a busy week for Texan weed reform, the House passed bills to decriminalize cannabis and expand medical access Jared GnamApril 30, 2021